| Issue Date | Title | Author(s) |
| 2024-05-17 | Cannabidiol oil or placebo in advanced cancer-disease progression and survival: a secondary analysis. | O'Leary, C; Greer, R; Huggett, G; Good, P; Gurgenci, T; Hardy, J |
| 2024-05-30 | Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. | Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P |
| 2023-10-14 | Exploring potential anti-inflammatory effects of medicinal cannabis. | Gurgenci, T; Kijanka, G; Greer, R; Huggett, G; Good, P; Moniruzzaman, M; Hardy, J |
| 2019-10-01 | The Impact of Provision of Professional Language Interpretation on Length of Stay and Readmission Rates in an Acute Care Hospital Setting | Abbato, S; Greer, R; Ryan, J; Vayne-Bossert, P; Good, P |
| 2024-05-01 | Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. | Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P |
| 2010-08-01 | Multi-modal distraction. Using technology to combat pain in young children with burn injuries | Miller, K; Rodger, S; Bucolo, S; Greer, R; Kimble, RM |
| 2019-12-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) | Good, P; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Hardy, J |
| 2020-07-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). | Hardy, J; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Good, P |
| 2023-03-01 | Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). | Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P |
| 2017-01 | Rates and Predictors of Professional Interpreting Provision for Patients With Limited English Proficiency in the Emergency Department and Inpatient Ward. | Ryan, J; Abbato, S; Greer, R; Vayne-Bossert, P; Good, P |
